Author

Kimberly Adao

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Observed institutions: National Institutes of Health, National Institute of Environmental Health Sciences, National Institute of Allergy and Infectious Diseases, National Institutes of Health Clinical Center

OpenAlex ID: A5047330920

Communication Challenges in High-Containment Clinical Environments

2021 · Meghan Schlosser, Kimberly Adao, et al. · AJN American Journal of Nursing · 5

593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

2025 · Luca Tudor Giurgea, Alison Han, et al. · Open Forum Infectious Diseases · 3

Safety and immunogenicity of a BPL-inactivated, whole-virus, universal influenza vaccine: a randomized, double-blinded, double-dummy, placebo-controlled, phase 1 clinical trial

2026 · Luca T. Giurgea, Alison Han, et al. · Nature Communications

Works count: 3

Citation count: 8

H-index: 2

I10-index: